Lysis Buffer for Reliable Mouse Genotyping
2026-09-25
Build a consistent mouse genotyping workflow around a lysis buffer designed to release genomic DNA from tail, toe, or ear tissue. This practical guide covers sample handling, kit-aware optimization, and troubleshooting—while distinguishing the CRC biomarker study’s findings from what mouse genotyping can establish.
Concanavalin A Blocks Conserved Coronavirus Spike Glycans
2026-09-24
Guo and colleagues report that concanavalin A (ConA) inhibits coronavirus entry by binding conserved, mannose-rich N-linked glycans near the spike S2′ cleavage site and interfering with spike activation. Evidence from fusion, entry, infection, biochemical, and mouse models supports this mechanism, while leaving questions about therapeutic safety and transfer to human disease for future study.
Indometacin Sodium for PSC Inflammation Assays
2026-09-24
Use Indometacin Sodium to probe how COX-linked prostaglandin signaling relates to pancreatic stellate cell activation, migration, and viability. This workflow pairs dose-response testing with orthogonal molecular and functional readouts, while flagging the controls needed to distinguish pathway modulation from general cytotoxicity.
Netarsudil and Predictive siRNA Codelivery
2026-09-23
Slaughter and colleagues developed a quantitative framework linking ionizable drug structure to siRNA complexation and nanoparticle encapsulation. Netarsudil emerged as a high-performing candidate and enabled codelivery of CTGF-targeting siRNA in fibrotic human trabecular meshwork cells, where reduced CTGF expression and actin network density were observed.
ZK53: Mapping ClpP Activation to Cancer Phenotypes
2026-09-23
ZK53 is a selective human mitochondrial serine protease ClpP activator that connects mitochondrial proteostasis to cell-cycle arrest, apoptosis, and ferroptosis sensitivity. This article presents an assay-to-phenotype framework for choosing biochemical, cellular, and in vivo validation strategies.
RIPA Lysis Buffer (Medium) for EV Signaling
2026-09-22
Translate MRSA extracellular-vesicle stimulation into pathway-ready cell and tissue lysates for Western blotting, ELISA, and immunoprecipitation. This practical workflow pairs balanced detergent lysis with inhibitor-aware handling and controls suited to IL-8-linked cancer signaling studies.
Pexidartinib (PLX3397) in Macrophage Research
2026-09-21
Pexidartinib (PLX3397) gives researchers a selective CSF1R-centered way to interrogate macrophage and microglial biology, from tumor co-cultures to neuroimmune models. This workflow connects tumor microenvironment macrophage modulation with the reference study’s synapse-focused analysis of alcohol-induced seizure susceptibility while clearly separating validated findings from testable extensions.
ARCA-Capped mRNA: Translational Leverage
2026-09-21
A mechanistic and strategic guide to ARCA capping, poly(A) design, and reproducible mRNA workflows for cancer vaccines, translation assays, and broader RNA research.
Ertapenem and the Next Wave of Resistance Mapping
2026-09-20
Ertapenem sodium salt can serve as a mechanistic and phenotypic anchor for translational antibiotic resistance research. This article connects PBP inhibition, carbapenemase gene mobility, assay design, pharmacokinetic context, and hospital-level transmission dynamics to support more informative resistance profiling.
Praeruptorin A, ERK/MMP1, and HCC Metastasis
2026-09-19
The reference study shows that praeruptorin A suppresses migration and invasion of human hepatocellular carcinoma cells without evident cytotoxicity or cell-cycle disruption. Its mechanistic contribution is the connection between ERK pathway activation, MMP1 downregulation, and a reversible antimetastatic phenotype, although the evidence remains limited to cell-based models.
Superoxide Dismutase Activity Assay Kit Workflow
2026-09-19
Build a 30-minute colorimetric SOD workflow for comparing antioxidant defenses across biological samples, while controlling matrix effects and plate-to-plate variability. The guide also shows when a SOD Activity Assay should complement—not replace—mitochondrial H2O2 measurements based on Amplex Red.
Paroxetine: Molecular Mechanisms and Research Implications
2026-09-18
The 2021 review by Kowalska and colleagues maps paroxetine pharmacology beyond serotonin transporter blockade, integrating evidence on cytochrome P450 enzymes, monoamine transporters, GRK2, and viral glycoprotein interactions. Its main practical contribution is a target-oriented framework for interpreting paroxetine experiments while distinguishing established SSRI biology from exploratory applications in kinase, oncology, and antiviral research.
Telmisartan for Reliable Cardiac Assays
2026-09-18
This scenario-driven guide explains how Telmisartan (SKU A8531) can improve interpretation of angiotensin II cardiac hypertrophy, viability, and cytotoxicity assays. It covers receptor-specific experimental design, DMSO formulation, protocol controls, mechanistic comparisons, and practical product-selection criteria.
Regorafenib (BAY 73-4506): Reliable Assays
2026-09-17
A scenario-driven guide to using Regorafenib (BAY 73-4506), SKU A8236, in viability, proliferation, migration, and invasion assays. It connects formulation handling with concentration selection, mechanistic controls, and interpretation of melanoma and angiogenesis research data.
Aneugen Molecular Mechanism Assay: Key Findings
2026-09-17
Bernacki and colleagues developed a tiered flow-cytometric strategy that distinguishes tubulin stabilization, tubulin destabilization, and mitotic kinase inhibition among aneugenic chemicals. Using 27 reference compounds, fluorescent Taxol responses, mitotic markers, hierarchical clustering, and an artificial neural network, the study demonstrated a practical route from genotoxicity detection to molecular-mechanism assignment.